The potential of antihistamines in causing the death of leukaemic stem cells
Acute myeloid leukaemia (AML) has one of the worst prognosis of all leukaemias. Its treatment with chemotherapy…
Browsing: Leukaemia
Drug combo heralds major shift in chronic lymphocytic leukaemia treatment
A combination of two drugs keeps patients with chronic lymphocytic leukaemia disease-free and alive longer…
Hidden chemistry in flowers shown to kill cancer cells
Researchers at the University of Birmingham have shown that it’s possible to produce a compound…
New drug provides hope for babies with aggressive acute lymphoblastic leukaemia
A breakthrough new drug is providing hope to tiny babies at risk of dying from…
A heart failure drug to treat leukaemia: a promising new therapeutic approach
Canadian researchers followed their intuition that a drug initially intended for heart failure could be…
EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously untreated patients with chronic lymphocytic leukaemia and coexisting comorbidities
The current standard of care for patients with chronic lymphocytic leukaemia (CLL) and coexisting conditions…
EHA 2019: Genomic evidence of residual disease in patients in remission prior to stem cell transplant; fate or opportunity for early intervention?
Acute myeloid leukaemia (AML) is a rare, highly fatal blood cancer. Allogeneic haematopoietic cell transplantation…
EHA 2019: Burning out the T-ALL engine: NADK is a new therapeutic target in T-cell Acute Lymphoblastic Leukaemia
T-cell acute lymphoblastic leukaemia (T-ALL) is an aggressive cancer which is lethal to 15% of…
EHA 2019: Acalabrutinib shows remarkable benefit in relapsed or refractory chronic lymphocytic leukaemia
The Phase III ASCEND study of the Bruton’s Tyrosine Kinase inhibitor (BTKi) acalabrutinib in relapsed…
Study reports ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia (CLL), have been shown…